Related references
Note: Only part of the references are listed.Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection
Paul Feuerstadt et al.
DIGESTIVE DISEASES AND SCIENCES (2022)
Identification of ADS024, a newly characterized strain of Bacillus velezensis with direct Clostridiodes difficile killing and toxin degradation bio-activities
Michelle M. O'Donnell et al.
SCIENTIFIC REPORTS (2022)
RBX7455, a Non-frozen, Orally Administered Investigational Live Biotherapeutic, Is Safe, Effective, and Shifts Patients' Microbiomes in a Phase 1 Study for Recurrent Clostridioides difficile Infections
Sahil Khanna et al.
CLINICAL INFECTIOUS DISEASES (2021)
Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults
Stuart Johnson et al.
CLINICAL INFECTIOUS DISEASES (2021)
Therapeutic Mechanism of Macrophage Inflammatory Protein 1 α Neutralizing Antibody (CCL3) in Clostridium difficile Infection in Mice
Jiani Wang et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Mechanism of Antibacterial Activity of Bacillus amyloliquefaciens C-1 Lipopeptide toward Anaerobic Clostridium difficile
Jia Lv et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Real-world Experience of Bezlotoxumab for Prevention of Clostridioides difficile Infection: A Retrospective Multicenter Cohort Study
Richard L. Hengel et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Live Biotherapeutic Products, A Road Map for Safety Assessment
Alice Rouanet et al.
FRONTIERS IN MEDICINE (2020)
Cell death in the gut epithelium and implications for chronic inflammation
Jay V. Patankar et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
Zachariah DeFilipp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Innate Immune Response and Outcome of Clostridium difficile Infection Are Dependent on Fecal Bacterial Composition in the Aged Host
Jae Hyun Shin et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
L. Clifford McDonald et al.
CLINICAL INFECTIOUS DISEASES (2018)
Purification and characterization of fibrinolytic protease from Bacillus amyloliquefaciens MCC2606 and analysis of fibrin degradation product by MS/MS
Yogesh Devaraj et al.
PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY (2018)
Fidaxomicin and OP-1118 Inhibit Clostridium difficile Toxin A-and B-Mediated Inflammatory Responses via Inhibition of NF-κB Activity
Hon Wai Koon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Timely Use of Probiotics in Hospitalized Adults Prevents Clostridium difficile Infection: A Systematic Review With Meta-Regression Analysis
Nicole T. Shen et al.
GASTROENTEROLOGY (2017)
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
M. H. Wilcox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Bacillus amyloliquefaciens, Bacillus velezensis, and Bacillus siamensis Form an Operational Group B. amyloliquefaciens within the B-subtilis Species Complex
Ben Fan et al.
FRONTIERS IN MICROBIOLOGY (2017)
National epidemiology of initial and recurrent Clostridium difficile infection in the Veterans Health Administration from 2003 to 2014
Kelly R. Reveles et al.
PLOS ONE (2017)
Cytokines Are Markers of the Clostridium difficile-Induced Inflammatory Response and Predict Disease Severity
Hua Yu et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Probiotics as adjunctive therapy for preventing Clostridium difficile infection - What are we waiting for?
Jennifer K. Spinler et al.
ANAEROBE (2016)
Systematic Review: Adverse Events of Fecal Microbiota Transplantation
Sinan Wang et al.
PLOS ONE (2016)
Controversies Around Epidemiology, Diagnosis and Treatment of Clostridium difficile Infection
Fawziah Marra et al.
DRUGS (2015)
Fecal microbiota transplantation for Clostridium difficile infection: back to the future
Guglielmo Borgia et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
The role of Gr-1+ cells and tumour necrosis factor-α signalling during Clostridium difficile colitis in mice
Andrew J. McDermott et al.
IMMUNOLOGY (2015)
Bacillus amyloliquefaciens as prophylactic treatment for Clostridium difficile-associated disease in a mouse model
S. Geeraerts et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison
Oliver A. Cornely et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Human Monoclonal Antibodies against Clostridium difficile Toxins A and B Inhibit Inflammatory and Histologic Responses to the Toxins in Human Colon and Peripheral Blood Monocytes
Hon Wai y Koon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials
Derrick W. Crook et al.
CLINICAL INFECTIOUS DISEASES (2012)
Clostridium difficile Toxins: Mediators of Inflammation
Aimee Shen
JOURNAL OF INNATE IMMUNITY (2012)
Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
Oliver A. Cornely et al.
LANCET INFECTIOUS DISEASES (2012)
The role of toxin A and toxin B in Clostridium difficile infection
Sarah A. Kuehne et al.
NATURE (2010)
Expression of recombinant Clostridium difficile toxin A and B in Bacillus megaterium
Guilin Yang et al.
BMC MICROBIOLOGY (2008)
Comparative analysis of the complete genome sequence of the plant growth-promoting bacterium Bacillus amyloliquefaciens FZB42
Xiao Hua Chen et al.
NATURE BIOTECHNOLOGY (2007)
Substance P mediates antiapoptotic responses in human colonocytes by Akt activation
Hon-Wai Koon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Lactobacillus sepsis associated with probiotic therapy
MH Land et al.
PEDIATRICS (2005)
Purification and characterization of proteases from Bacillus amyloliquefaciens isolated from traditional soybean fermentation starter
SJ Cho et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2003)
Mechanism of Clostridium difficile toxin A-induced apoptosis in T84 cells
GAC Brito et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Share Paper
